Skip to content

Clinical trials

Hepatitis B trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B Country / region: France Clear all

79 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20031
20052
20062
20073
20084
20094
20104
20113
20123
20131
20143
20152
20162
20172
20183
20193
20203
20215
20226
20232
20248
20253
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed40
Unknown status11
Recruiting9
Terminated8
Active, not recruiting5
Not yet recruiting3
No longer available1
Suspended1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline11
Gilead Sciences6
Hospices Civils de Lyon5
ANRS, Emerging Infectious Diseases4
Assistance Publique - Hôpitaux de Paris4
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba3
University Hospital, Grenoble3
University Hospital, Limoges3
Bristol-Myers Squibb2
French National Agency for Research on AIDS and Viral Hepatitis2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B79
Hepatitis B, Chronic20
Hepatitis C17
HIV Infections9
Hepatitis9
Carcinoma, Hepatocellular6
Fibrosis6
Hepatitis, Chronic6
Liver Cirrhosis6
Acquired Immunodeficiency Syndrome5

Trials

Showing 51 to 75 of 79. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.